Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells

References

• World Health Organization. Diabetes; 2017. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed Nov 7, 2017.
   Google Scholar
• DeFronzo RA. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia. 1992;35(4):389–397. doi:10.1007/BF00401208
   PubMedGoogle Scholar
• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–846. doi:10.1038/nature05482
   PubMed Web of Science ®Google Scholar
• Sauter NS, Thienel C, Plutino Y, et al. Angiotensin II induces interleukin-1 beta-mediated islet inflammation and beta-cell dysfunction independently of vasoconstrictive effects. Diabetes. 2015;64(4):1273–1283. doi:10.2337/db14-1282
   PubMedGoogle Scholar
• Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia. 2004;47(2):240–248. doi:10.1007/s00125-003-1295-1
   PubMed Web of Science ®Google Scholar
• Pahlavani M, Kalupahana NS, Ramalingam L, Moustaid-Moussa N. Regulation and functions of the renin-angiotensin system in white and brown adipose tissue. Compr Physiol. 2017;7(4):1137–1150. doi:10.1002/cphy.c160031
   PubMedGoogle Scholar
• Abuissa H, Jones PG, Marso SP, O’Keefe JH Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 2005;46(5):821–826. doi:10.1016/j.jacc.2005.05.051
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obesity Rev. 2012;13(2):136–149.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369(9568):1208–1219.
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Massiera F, Quignard-Boulange A, et al. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity. 2012;20(1):48–56. doi:10.1038/oby.2011.299
   PubMed Web of Science ®Google Scholar
• Ramalingam L, Menikdiwela K, LeMieux M, et al. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance. Biochim Biophys Acta. 2016.
   Google Scholar
• Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue renin-angiotensin system in human pancreas. J Endocrinol. 1999;161(2):317–322. doi:10.1677/joe.0.1610317
   PubMed Web of Science ®Google Scholar
• Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab. 2004;30(6):498–505. doi:10.1016/S1262-3636(07)70147-7
   PubMed Web of Science ®Google Scholar
• Devereux RB, Dahlof B, Kjeldsen SE, et al. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. Ann Intern Med. 2003;139(3):169–177.
   PubMed Web of Science ®Google Scholar
• van der Zijl NJ, Moors CCM, Goossens GH, Hermans MMH, Blaak EE, Diamant M. Valsartan improves beta-cell function and insulin sensitivity in subjects with impaired glucose metabolism a randomized controlled trial. Diab Care. 2011;34(4):845–851. doi:10.2337/dc10-2224
   PubMedGoogle Scholar
• Group NS, McMurray JJ, Holman RR, et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362(16):1477–1490. doi:10.1056/NEJMoa1001121
   PubMedGoogle Scholar
• Lupi R, Del Guerra S, Bugliani M, et al. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur j Endocrinol/Eur Federation Endocr Soc. 2006;154(2):355–361. doi:10.1530/eje.1.02086
   PubMedGoogle Scholar
• Frantz ED, Crespo-Mascarenhas C, Barreto-Vianna AR, Aguila MB, Mandarim-de-Lacerda CA. Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. PLoS One. 2013;8(7):e67192. doi:10.1371/journal.pone.0067192
   PubMedGoogle Scholar
• Chhabra KH, Xia H, Pedersen KB, Speth RC, Lazartigues E. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice. Am J Physiol Endocrinol Metab. 2013;304(8):E874884. doi:10.1152/ajpendo.00490.2012
   Google Scholar
• Chu KY, Leung PS. Angiotensin II Type1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal. 2007;9(7):869–878.
   PubMedGoogle Scholar
• Menikdiwela KR, Ramalingam L, Allen L, Scoggin S, Kalupahana NS, Moustaid-Moussa N. Angiotensin II increases endoplasmic reticulum stress in adipose tissue and adipocytes. Sci Rep. 2019;9(1):8481. doi:10.1038/s41598-019-44834-8
   PubMedGoogle Scholar
• Menikdiwela KR, Ramalingam L, Abbas MM, et al. Role of microRNA 690 in mediating angiotensin II effects on inflammation and endoplasmic reticulum stress. Cells. 2020;9(6):1327. doi:10.3390/cells9061327
   PubMed Web of Science ®Google Scholar
• Acosta-Montano P, Garcia-Gonzalez V. Effects of dietary fatty acids in pancreatic beta cell metabolism, implications in homeostasis. Nutrients. 2018;10:4.
   Google Scholar
• Scheuner D, Kaufman RJ. The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev. 2008;29(3):317–333. doi:10.1210/er.2007-0039
   PubMed Web of Science ®Google Scholar
• Marchetti P, Bugliani M, Lupi R, et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia. 2007;50(12):2486–2494. doi:10.1007/s00125-007-0816-8
   PubMedGoogle Scholar
• Malhi H. MicroRNAs in ER stress: divergent roles in cell fate decisions. Curr Pathobiol Rep. 2014;2(3):117–122.
   PubMedGoogle Scholar
• Sharma RB, O’Donnell AC, Stamateris RE, et al. Insulin demand regulates beta cell number via the unfolded protein response. J Clin Invest. 2015;125(10):3831–3846. doi:10.1172/JCI79264
   PubMedGoogle Scholar
• Chen M, Ma G, Yue Y, et al. Downregulation of the miR-30 family microRNAs contributes to endoplasmic reticulum stress in cardiac muscle and vascular smooth muscle cells. Int J Cardiol. 2014;173(1):65–73. doi:10.1016/j.ijcard.2014.02.007
   PubMed Web of Science ®Google Scholar
• Menikdiwela KR, Ramalingam L, Rasha F, et al. Autophagy in metabolic syndrome: breaking the wheel by targeting the renin–angiotensin system. Cell Death Dis. 2020;11(2):1–17. doi:10.1038/s41419-020-2275-9
   PubMed Web of Science ®Google Scholar
• Ramracheya RD, Muller DS, Wu Y, et al. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia. 2006;49(2):321–331. doi:10.1007/s00125-005-0101-7
   PubMedGoogle Scholar
• Chu KY, Leung PS. Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci. 2009;10(1):75–84. doi:10.2174/138920309787315176
   PubMed Web of Science ®Google Scholar
• Leung PS, Carlsson PO. Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Pancreas. 2005;30(4):293–298.
   PubMedGoogle Scholar
• Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia. 1998;41(2):127–133.
   PubMedGoogle Scholar
• Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 2008;29(1):42–61. doi:10.1210/er.2007-0015
   PubMed Web of Science ®Google Scholar
• Ribeiro-Oliveira JA, Nogueira AI, Pereira RM, Boas WWV, Dos Santos RAS, e Silva ACS. The renin–angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008;4(4):787. doi:10.2147/VHRM.S1905
   PubMedGoogle Scholar
• Yayama K, Okamoto H. Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. Int Immunopharmacol. 2008;8(2):312–318. doi:10.1016/j.intimp.2007.06.012
   PubMedGoogle Scholar
• Madec AM, Cassel R, Dubois S, et al. Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway. FASEB J. 2013;27(12):5122–5130. doi:10.1096/fj.13-234104
   PubMedGoogle Scholar
• Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes. 2006;55(2):367–374. doi:10.2337/diabetes.55.02.06.db05-1022
   PubMedGoogle Scholar
• Kemp BA, Howell NL, Keller SR, Gildea JJ, Padia SH, Carey RM. AT2 receptor activation prevents sodium retention and reduces blood pressure in angiotensin II-dependent hypertension. Circ Res. 2016;119(4):532–543. doi:10.1161/CIRCRESAHA.116.308384
   PubMedGoogle Scholar
• Liu M, Jing DQ, Wang Y, Liu Y, Yin SN. Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells. Mol Cell Biochem. 2015;400(12):233–244. doi:10.1007/s11010-014-2280-3
   PubMedGoogle Scholar
• Keller MP, Choi Y, Wang P, et al. A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res. 2008;18(5):706–716. doi:10.1101/gr.074914.107
   PubMed Web of Science ®Google Scholar
• Hansson L. Clinical studies with candesartan. Drugs Today. 1999;35(2):117–126. doi:10.1358/dot.1999.35.2.527967
   PubMedGoogle Scholar
• Dahlof B, Zanchetti A, Diez J, et al. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens. 2002;20(9):1855–1864. doi:10.1097/00004872-200209000-00032
   PubMedGoogle Scholar
• van der Zijl NJ, Serne EH, Goossens GH, et al. Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism. J Hypertens. 2011;29(10):1955–1962.
   PubMedGoogle Scholar
• Kim MK, Kim HS, Lee IK, Park KG. Endoplasmic reticulum stress and insulin biosynthesis: a review. Exp Diabetes Res. 2012.
   Google Scholar
• Sahr A, Wolke C, Maczewsky J, et al. The angiotensin-(17)/mas axis improves pancreatic beta-cell function in vitro and in vivo. Endocrinology. 2016;157(12):4677–4690. doi:10.1210/en.2016-1247
   PubMedGoogle Scholar
• Gletsu N, Doan TN, Cole J, Sutliff RL, Bernstein KE. Angiotensin II-induced hypertension in mice caused an increase in insulin secretion. Vascul Pharmacol. 2005;42(3):83–92. doi:10.1016/j.vph.2005.01.006
   PubMedGoogle Scholar
• Maedler K, Schumann DM, Sauter N, et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes. 2006;55(10):2713–2722. doi:10.2337/db05-1430
   PubMedGoogle Scholar
• Spinas GA, Mandrup-Poulsen T, Molvig J, et al. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol. 1986;113(4):551–558. doi:10.1530/acta.0.1130551
   PubMedGoogle Scholar
• Kim S, Voy BH, Huang T, et al. Angiotensin II uses insulin signalling pathways in 3T3-L1 adipocytes. Adipocytes. 2005;1(4):239–248.
   Google Scholar
• Kuno A, Yamada T, Masuda K, et al. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology. 2003;124(4):1010–1019.
   PubMed Web of Science ®Google Scholar
• Yamada T, Kuno A, Masuda K, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther. 2003;307(1):17–23.
   PubMedGoogle Scholar
• Li TT, Jia LX, Zhang WM, et al. Endoplasmic reticulum stress in bone marrow-derived cells prevents acute cardiac inflammation and injury in response to angiotensin II. Cell Death Dis. 2016;7(6):e2258.
   PubMedGoogle Scholar
• Wang J, Wen Y, Lv LL, et al. Involvement of endoplasmic reticulum stress in angiotensin II-induced NLRP3 inflammasome activation in human renal proximal tubular cells in vitro. Acta Pharmacol Sin. 2015;36(7):821–830. doi:10.1038/aps.2015.21
   PubMedGoogle Scholar
• Willy JA, Young SK, Stevens JL, Masuoka HC, Wek RC. CHOP links endoplasmic reticulum stress to NF-kappaB activation in the pathogenesis of nonalcoholic steatohepatitis. Mol Biol Cell. 2015;26(12):2190–2204. doi:10.1091/mbc.E15-01-0036
   PubMed Web of Science ®Google Scholar
• Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103(5):398–406. doi:10.1007/s00395-008-0733-0
   PubMed Web of Science ®Google Scholar
• Byrd AE, Brewer JW. Micro(RNA)managing endoplasmic reticulum stress. IUBMB Life. 2013;65(5):373–381.
   PubMed Web of Science ®Google Scholar
• Chappell MC. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol. 2016;310(2):H137152. doi:10.1152/ajpheart.00618.2015
   Google Scholar
• Schulz A, Jankowski J, Zidek W, Jankowski V. Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS. Clin Proteomics. 2014;11(1):37. doi:10.1186/1559-0275-11-37
   PubMedGoogle Scholar
• Harte A, McTernan P, Chetty R, et al. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation. 2005;111(15):1954–1961. doi:10.1161/01.CIR.0000161954.17870.5D
   PubMedGoogle Scholar
• Chappell MC, Millsted A, Diz DI, Brosnihan KB, Ferrario CM. Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens. 1991;9(8):751–759. doi:10.1097/00004872-199108000-00008
   PubMedGoogle Scholar
• Kitakaze K, Kurahashi K, Miyake M, Hamada Y, Oyadomari M, Oyadomari S. Targeted deletion of ATF4 in ß cells leads to the vulnerability and dedifferentiation during ER stress. Diabetes. 2018;67(Supplement 1):2104P. doi:10.2337/db18-2104-P
   Google Scholar